EU
SLDB icon

Emory University’s Solid Biosciences SLDB Stock Holding History

Emory University’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,926
Closed -$2.75M – 49
2019
Q1 		$2.75M Buy
19,926
+15,345
+335% +$3.84M 1.93% 9
2018
Q4 		$1.84M Sell
4,581
-71
-2% -$33.4K 1.45% 28
2018
Q3 		$3.29M Buy
+4,652
New +$2.92M 2.15% 6

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Emory University's SLDB Position: Q2 2019 in Review

Emory University sold out of Solid Biosciences (SLDB) in Q2 2019, closing a stake of 19,926 shares — an estimated $2.75M sold.

Emory University first reported a position in SLDB in Q3 2018 and held it in 3 quarters. The position peaked at $3.29M in Q3 2018. 74 funds tracked by Wall St. Rank hold SLDB as of Q2 2019.

  • Emory University reported no remaining Solid Biosciences position as of Q2 2019 after selling out during the quarter.
  • Emory University sold 19,926 Solid Biosciences shares in Q2 2019, an estimated $2.75M.
  • Emory University first reported a position in Solid Biosciences in Q3 2018 and held it in 3 quarters.
  • Emory University's Solid Biosciences position peaked at $3.29M in Q3 2018.
  • 74 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2019.

Based on Emory University's 13F filing for Q2 2019, filed 14 Aug 2019.